Clinical Study
Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
Table 2
Treatments and pathological reports.
| | Parameters | (%) |
| | Surgical procedures | | | Lobectomy | 114 (91.9) | | Bilobectomy (RUL and RML) | 1 (0.8) | | Bilobectomy (RLL and RML) | 9 (7.3) | | Histologic types | | | Adenocarcinoma | 70 (56.5) | | Squamous cell carcinoma | 33 (26.6) | | Bronchioloalveolar carcinoma | 10 (8.1) | | Large cell carcinoma | 5 (4.0) | | Neuroendocrine tumor | 3 (2.4) | | Adenoid cystic CA | 2 (1.6) | | Adenosquamous | 1 (0.8) | | Tumor grading | | | Well differentiated | 41 (33.1) | | Moderately differentiated | 45 (36.3) | | Poorly differentiated | 24 (19.4) | | Undifferentiated | 5 (4.0) | | Mucinous type (BAC) | 5 (4.0) | | Nonmucinous type (BAC) | 4 (3.2) | | Pathological staging | | | IA | 33 (26.6) | | IB | 45 (36.3) | | IIA | 21 (16.9) | | IIB | 25 (20.2) | | Tumor diameter (cm) | | | ≤3 | 33 (26.6) | | >3 | 91 (73.4) | | Tumor necrosis | 48 (38.7) | | Visceral pleural invasion | 23 (18.6) | | Neural invasion | 2 (1.6) | | Intratumoral lymphatic invasion | 91 (73.4) | | Intratumoral blood vessel invasion | 40 (32.3) | | Follow-up time (months) | | | Tumor recurrence | 53 (42.7) | | Death | 47 (37.9) |
|
|
